Medicare Enrolled
Dr. Gabriel Carabulea, M.D.
Hematology & Oncology · San Clemente, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Carabulea from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carabulea?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carabulea
Dr. Gabriel Carabulea is a hematology & oncology specialist in San Clemente, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Carabulea performed 21,341 Medicare services across 489 unique beneficiaries.
Between the years covered by Open Payments, Dr. Carabulea received a total of $7,315 from 54 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carabulea is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in CA
$7,315 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,341
Medicare services
Top 23% in CA for hematology & oncology
489
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,067 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
16,830 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,601 | $0 | $2 |
| Anti-nausea injection (ondansetron/Zofran) | 1,345 | $0 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
406 | $103 | $185 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
246 | $26 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
121 | $12 | $37 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
121 | $13 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
113 | $54 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
98 | $74 | $137 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
89 | $118 | $246 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
86 | $1 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
81 | $143 | $239 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
60 | $7 | $100 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
45 | $1 | $10 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
41 | $27 | $40 |
| New patient office visit, complex (60-74 min) | 40 | $188 | $389 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
18 | $0 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
81.0% high complexity
15.9% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,315
Total received (2018-2024)
Avg $1,045/year across 7 years
Top 37% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,291 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$759
2023
$1,501
2022
$1,180
2021
$1,122
2020
$757
2019
$946
2018
$1,050
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$227
Regeneron Healthcare Solutions, Inc.
$98
ARRAY BIOPHARMA INC
$73
Takeda Pharmaceuticals U.S.A., Inc.
$60
Sumitomo Pharma America, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$51
Novartis Pharmaceuticals Corporation
$48
Mirati Therapeutics, Inc.
$39
Exelixis Inc.
$36
Janssen Biotech, Inc.
$36
Adaptive Biotechnologies Corporation
$20
AstraZeneca Pharmaceuticals LP
$19
Top 3 companies account for 52.4% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$759
E.R. Squibb & Sons, L.L.C.
$549
Regeneron Healthcare Solutions, Inc.
$514
Amgen Inc.
$431
AstraZeneca Pharmaceuticals LP
$390
GENZYME CORPORATION
$384
Lilly USA, LLC
$296
Merck Sharp & Dohme Corporation
$270
Novartis Pharmaceuticals Corporation
$260
Celgene Corporation
$231
Sumitomo Pharma America, Inc.
$201
Ipsen Biopharmaceuticals, Inc
$194
Pharmacyclics LLC, An AbbVie Company
$173
Janssen Biotech, Inc.
$170
Kite Pharma, Inc.
$168
EMD Serono, Inc.
$162
Blueprint Medicines Corporation
$142
GlaxoSmithKline, LLC.
$137
Gilead Sciences, Inc.
$136
Servier Pharmaceuticals LLC
$131
ARRAY BIOPHARMA INC
$126
Takeda Pharmaceuticals U.S.A., Inc.
$117
Mirati Therapeutics, Inc.
$87
Bayer HealthCare Pharmaceuticals Inc.
$81
Daiichi Sankyo Inc.
$81
Incyte Corporation
$78
Puma Biotechnology, Inc.
$72
Foundation Medicine, Inc.
$64
Clovis Oncology, Inc.
$60
Astellas Pharma US Inc
$57
Epizyme, Inc.,
$57
INSYS Therapeutics Inc
$56
Taiho Oncology, Inc.
$54
Merck Sharp & Dohme LLC
$54
AMAG Pharmaceuticals, Inc.
$50
Pharmacyclics LLC, an AbbVie Company
$49
Agios Pharmaceuticals, Inc.
$47
Myovant Sciences Inc.
$44
Dendreon Pharmaceuticals LLC
$42
Exelixis Inc.
$36
MEDIVATION FIELD SOLUTIONS LLC
$36
Rigel Pharmaceuticals, Inc.
$35
AbbVie, Inc.
$34
Karyopharm Therapeutics Inc.
$29
TG THERAPEUTICS, INC.
$24
Alnylam Pharmaceuticals Inc.
$24
SANOFI-AVENTIS U.S. LLC
$22
Adaptive Biotechnologies Corporation
$20
Intercept Pharmaceuticals, Inc.
$17
West Therapeutics Development, LLC
$15
Shire North American Group Inc
$14
EISAI INC.
$13
Seattle Genetics, Inc.
$12
Dova Pharmaceuticals
$11
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BAVENCIO · BLENREP · BRAFTOVI · Bavencio · CABOMETYX · CALQUENCE · CYRAMZA · DARZALEX · DIFICID · Doptelet · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · FASLODEX · FERAHEME · FOUNDATIONONE · GAVRETO · GIVLAARI · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OCALIVA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PLUVICTO · PROVENGE · PYRUKYND · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · Subsys · TAGRISSO · TAZVERIK · TIBSOVO · Tavalisse · UKONIQ · VERZENIO · VPRIV · Venclexta · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
44
Per 100K population
1.4
County median income
$113,702
Nearest hospital
ALISO RIDGE BEHAVIORAL HEALTH, LLC
10.0 mi
10.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Carabulea is a mixed practice specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Carabulea experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Carabulea performed 16,830 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carabulea receive payments from pharmaceutical companies?
Yes. Dr. Carabulea received a total of $7,315 from 54 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carabulea's costs compare to other hematology & oncology specialists in San Clemente?
Dr. Carabulea's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carabulea) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Clemente
Browse hematology & oncology specialists in San Clemente ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology